Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

PFE Stock Warning: Avoid This Big Pharma Value Trap at All Costs

PFE stock may look like a bargain among healthcare stocks, but despite its low valuation and high yield, further declines are likely.

TPST Stock: 7 Things to Know About Tempest Therapeutics

Are you curious about the recent surge from Tempest Therapeutics? Here's a closer look at this company and at TPST stock.

Wall Street Warms Up to Tempest as TPST Stock Surges 1,500%

TPST stock is surging higher after the company released new positive data concerning its TPST-1120 drug candidate.

7 Innovator Stocks Primed for Exceptional Growth

As the market continues to rebound, investors should keep an eye on these companies at the forefront of innovation. They stand poised to surge ahead of their competition in terms of revenue and earnings.

Why Is Ocugen (OCGN) Stock Up 5% Today?

Ocugen stock is rising higher on Tuesday thanks to OCGN investors celebrating news of a new clinical trial for its Covid-19 vaccine.

Why Is Akero Therapeutics (AKRO) Stock Down 58% Today?

Akero Therapeutics (stock is falling hard on Tuesday after the company failed to impress AKRO investors with its clinical trial results.

Why Is NuCana (NCNA) Stock Down Today?

NuCana stock is sliding lower as investors in NCNA prepare for presentations from the biopharmaceutical company later this week.

3 Shaky Stocks to Sell in October Before It’s Too Late

Indeed, bearish reasons prevail. If any sort of shock hits the market, I would argue that valuations aren't positioned to absorb any sort of hit. Thus, the market is priced for basically a soft landing currently.

7 F-Rated Stocks to Kick to the Curb in October

Why would you subject your portfolio – and your financial future to F-rated stocks that are likely to drag your earnings down?

Q4 Stock Predictions: 7 Penny Stocks Ready to Roar Into 2024

When it comes to stocks predictions for the current quarter, these seven penny stocks to buy could start or continue to crush it.

3 Biotech Stocks Ready to Break Out in 2024

Still, many biotech stocks to buy are positioned well for the coming quarter and new year. These show amazing drug portfolios, promising growth potential, and world-class technology.

Why Is RVL Pharmaceuticals (RVLP) Stock Up 28% Today?

RVL Pharmaceuticals stock is a hot topic on Friday as investors seek answers as to why RVLP stock is rally alongside heavy trading.

Why Is Vaccinex (VCNX) Stock Up 26% Today?

Vaccinex stock is climbing higher on Friday as investors react to company leaders recently acquiring more shares of VCNX stock.

The 7 Most Undervalued Penny Stocks to Buy in October 2023

Undervalued penny stocks offer tremendous return for investors with an appetite for risk but these shares are relatively safe as well.

Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar

But it's not time to give up on the stock market. In fact, thanks to the recent selling, bargains are springing up across many S&P 500 stocks.

Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream

These dividend aristocrats are some of the best options for long-term investors looking to boost their portfolio return.

Why Is MaxCyte (MXCT) Stock Down 21% Today?

MaxCyte stock is taking a beating on Thursday as investors in MXCT shares react to preliminary results for its third quarter of 2023.

SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today

Sandoz (SDZNY) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff from Novartis.

Short Sellers Are Betting Against Novavax (NVAX) Stock

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.